113 related articles for article (PubMed ID: 37635596)
1. Cyclin D1 expression, clinicopathological characteristics, and 2-year survival rate of gastric cancer in Cipto Mangunkusumo General Hospital.
Cahyanur R; Utari AP; Rahadiani N
Niger J Clin Pract; 2023 Aug; 26(8):1057-1062. PubMed ID: 37635596
[TBL] [Abstract][Full Text] [Related]
2. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
3. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Gao P; Zhou GY; Liu Y; Li JS; Zhen JH; Yuan YP
World J Gastroenterol; 2004 Oct; 10(20):2936-9. PubMed ID: 15378768
[TBL] [Abstract][Full Text] [Related]
4. The Difference in the Cyclin D1 Expression in Advanced Stage Nasopharyngeal Cancer based on Treatment Response: A Retrospective Cohort Study.
Irawan C; Cahyanur R; Lisnawati L; Abdullah M; Yunus RE
Acta Med Indones; 2020 Apr; 52(2):147-154. PubMed ID: 32778629
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer.
Aoyagi K; Koufuji K; Yano S; Murakami N; Terasaki Y; Yamasaki Y; Takeda J; Tanaka M; Shirouzu K
Kurume Med J; 2000; 47(3):199-203. PubMed ID: 11059220
[TBL] [Abstract][Full Text] [Related]
7. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
Kumari S; Puneet ; Prasad SB; Yadav SS; Kumar M; Khanna A; Dixit VK; Nath G; Singh S; Narayan G
Med Oncol; 2016 May; 33(5):40. PubMed ID: 27034264
[TBL] [Abstract][Full Text] [Related]
9. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
Feakins RM; Nickols CD; Bidd H; Walton SJ
Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
[TBL] [Abstract][Full Text] [Related]
13. Lack of cyclin D1 overexpression in gastric carcinogenesis.
Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
[TBL] [Abstract][Full Text] [Related]
14. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
15. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
Ahn MJ; Kim BH; Jang SJ; Hong EK; Lee WM; Baik HK; Park HK; Lee CB; Ki M
J Korean Med Sci; 1998 Oct; 13(5):513-8. PubMed ID: 9811181
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
18. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers.
Oda K; Okabayashi T; Kataoka M; Takeda A; Shibuya Y; Orita K; Tanaka N
Res Commun Mol Pathol Pharmacol; 1999; 105(3):237-52. PubMed ID: 10954128
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
